5.2 Judicious Use of Antimicrobials & High-Risk Agents

Judicious use as a clinical habit

Judicious use of medicines means every recommendation or supply should have a clear indication, a favourable benefit–harm balance for this patient, and a plan for duration and review. For antimicrobials the public health stakes are higher because unnecessary use drives resistance, Clostridioides difficile risk, adverse effects, and false reassurance that delays proper care. For high-risk non-antimicrobials the stakes are individual catastrophic harm: bleeding, hypoglycaemia, cytopenias, overdose, and preventable hospitalisation.

On the APC Intern Written Examination, expect scenarios that reward restraint with reasons, not automatic product supply. AMH remains your dosing, interaction, and caution reference; APF supports counselling standards and cautionary labels.

Antimicrobial stewardship in community and transition care

Australian stewardship principles align with national quality use of medicines and hospital programs (for example antimicrobial stewardship frameworks used in accredited health services). In community pharmacy your levers include:

• Not promoting antibiotics for typical viral upper respiratory tract infections
• Explaining expected illness duration (for example many colds last 7–10 days; cough may persist longer)
• Supporting symptomatic care: fluids, rest, analgesia/antipyretic when appropriate, saline, honey in eligible children/adults, inhaler technique for reactive airways
• Checking that prescribed antibiotics match indication, dose, renal function, allergies, and interactions
• Encouraging completion of the prescribed course as directed by the prescriber/AMH regimen while also understanding that modern practice sometimes uses shorter evidence-based durations — do not invent shorter or longer courses yourself
• Flagging duplicate therapy (two agents from the same class without rationale)
• Supporting hospital discharge antibiotic plans: what changed, how long left, monitoring for allergy or severe diarrhoea, and when to seek review

At the hospital–community interface, reconciliation errors are common: antibiotic stopped in hospital but still listed on an old token; long-term prophylaxis continued unintentionally; or IV-to-oral switch counselling incomplete. Pharmacists who clarify the plan reduce both under-treatment and unnecessary exposure.

Viral versus bacterial presentations — reasoning, not slogans

Many patients believe coloured sputum, green mucus, or “feeling wretched” proves bacterial infection. Teach a more accurate frame:

Streptococcal sore throat, urinary tract infection, cellulitis, otitis media in selected ages, sexually transmitted infections, and true pneumonia are examples where antibacterials may be indicated — usually after clinical (and sometimes laboratory) assessment by an appropriate prescriber. Your job in primary care is often to triage and educate, not to invent a diagnosis to justify a non-prescription “antibiotic alternative” that is actually just another symptomatic product sold with false certainty.

Never recommend leftover antibiotics from a previous illness. Never endorse sharing antibiotics between family members. Both practices are unsafe and undermine stewardship.

Spectrum, duration, and “stronger” antibiotics

Stewardship prefers:

• Narrowest effective spectrum for the likely pathogen and site
• Adequate dose for site penetration and patient factors (weight, renal function)
• Appropriate route (oral when bioavailability and severity allow)
• Shortest effective duration supported by guidelines and the prescriber’s plan

“Stronger” is not a clinical category. A broad-spectrum agent is not better for a simple infection; it may be worse because of collateral damage to normal flora and resistance pressure. If a prescription appears mismatched (for example a reserve broad-spectrum oral agent for a minor self-limiting complaint without explanation), contact the prescriber professionally rather than silently dispensing and hoping.

Watch for drug–bug mismatch clues in exam vignettes: antibiotic historically inactive for the likely organism, inadequate UTI agent in pregnancy, or macrolide use without considering interactions (for example QT risk or CYP interactions with certain long-term medicines).

Allergy history: true allergy versus intolerance

A chart label saying “penicillin allergy” is not a complete clinical story. Clarify:

• What drug exactly (penicillin V, amoxicillin, flucloxacillin, cephalexin, unknown “penicillin”)?
• What happened (timing, rash type, swelling, breathing difficulty, anaphylaxis, severe skin reaction such as SJS/TEN, organ involvement)?
• How long ago, and any later tolerated related antibiotics?
• Was it predictable intolerance (nausea, diarrhoea, thrush, headache) rather than immune-mediated allergy?

Why this matters:

• Patients labelled allergic often receive broader, more toxic, or less effective alternatives.
• Some reported childhood rashes were viral exanthems coinciding with antibiotic use.
• Severe true allergies (anaphylaxis, severe cutaneous adverse reactions) require strict avoidance and emergency planning; trivial GI upset does not justify the same restrictions.

Document the clarified history and communicate material updates to the care team. Do not remove a serious allergy label casually, and do not ignore anaphylaxis history to “just try a course.” Cross-reactivity reasoning (for example some cephalosporins and penicillin history) is nuanced — use AMH and specialist guidance rather than absolute folk rules.

High-risk agents: supply checks and counselling focus

High-risk medicines deserve a slower, structured supply process even when legally the prescription is valid.

Methotrexate (weekly dosing disasters)

• Confirm once-weekly dosing for usual rheumatology/dermatology regimens (not daily unless a specialist oncology context is explicit and verified).
• Check folic acid co-therapy where used.
• Counsel on infection risk, mouth ulcers, unexplained bruising, breathlessness, and need for blood monitoring as directed.
• Watch interacting medicines (for example some antibiotics such as trimethoprim-containing products can be problematic — check AMH).
• Ensure labelling and consumer warnings make the weekly schedule unmistakable.

Warfarin and other anticoagulants

• For warfarin: INR monitoring plan, vitamin K consistency messaging without extreme diet myths, interacting antibiotics and NSAIDs, bleeding signs, and double-check dose changes after lab results.
• For DOACs: renal function relevance, adherence criticality, interactions, and procedures/dental work communication.
• Avoid adding OTC NSAIDs or high-dose fish oil casually without risk discussion.

Insulin

• Confirm product identity (basal vs bolus; brand/device), dose, timing with food for mealtime insulins, and hypoglycaemia recognition/treatment.
• Storage: in-use pens versus refrigerated stock.
• Device technique and needle supply.
• Sick-day thinking: when to seek advice if not eating or if glucose is high with ketones (as applicable to the patient’s plan).

Opioids

• Check dose, formulation (IR vs modified release), previous use, sedation/respiratory depression risk, alcohol and benzodiazepine co-use, and real-time prescription monitoring obligations where applicable.
• Counsel on constipation, driving impairment, secure storage, and not sharing.
• Be alert to early supply requests, multiple prescribers, and clinical red flags for misuse or diversion — professional judgment and legal checks still apply.

Oral chemotherapy / other oral anticancer agents

• Verify dose, cycle days, supportive medicines (antiemetics, supportive care), handling precautions, and toxicity return precautions (fever during neutropenia risk periods, uncontrolled vomiting, bleeding).
• These are not “ordinary S4 scripts” in counselling intensity even when the logistics resemble community dispensing.

Shared high-risk process habits

• Read the whole prescription and supporting notes.
• Reconcile with known history and recent discharge summaries when available.
• Use two-identifier patient checks.
• Apply cautionary advisory labels and spoken counselling that match the real risk.
• Know when to defer supply pending clarification.

Avoiding unnecessary medicines beyond antibiotics

Judicious use is broader than stewardship posters:

• Duplicate paracetamol from combination cold products
• Long-term proton pump inhibitors continued without indication review
• Sedating antihistamines for chronic insomnia without addressing cause
• Codeine-free but still inappropriate analgesic combinations stacked together
• Requests to “cover” a viral illness with leftover antibacterials plus multiple symptom cocktail packs that exceed safe paracetamol limits

Ask: What problem is this medicine solving, for how long, and what harm might it add? If you cannot answer, reassess.

Putting it together in exam vignettes

A high-scoring approach usually looks like:

1. Clarify diagnosis likelihood (viral vs bacterial vs non-infectious).
2. Identify patient risks (age, pregnancy, immunosuppression, allergies, renal function).
3. Choose non-drug and symptomatic options first when appropriate.
4. If an antimicrobial prescription is present, verify fit for purpose; if an OTC request implies antibiotic expectation, educate and refer when needed.
5. For high-risk chronic agents, prioritise error-prevention checks and toxicity counselling over speed.
6. Document material interventions and communicate with prescribers when therapy looks unsafe or incomplete.

Judicious use is not withholding care. It is precision care: antibiotics when infection physiology and guidelines support them, and meticulous respect for medicines that can kill when processes fail.